Comments
Loading...

Kymera Therapeutics

KYMRNASDAQ
Logo brought to you by Benzinga Data
$40.66
1.523.88%
At close: -
$40.90
0.240.59%
After Hours: Dec 20, 7:54 PM EDT

Kymera Therapeutics (NASDAQ:KYMR) Stock Quotes, Forecast and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
1
Jul
1
2
Aug
2
Sep
4
1
Nov
2
1
Dec
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$38.66
Close$40.66
Volume / Avg.1.15M / 454.36K
Day Range$38.24 - $40.78
52 Wk Range22.35 - 53.27
Market Cap$2.65B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
41
Short Interest
15.55%
Days to Cover19.01

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
KYMR
IDYA

FAQ

Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ:KYMR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kymera Therapeutics (KYMR) competitors?

Q

What is the forecast, or price target, for Kymera Therapeutics (KYMR) stock?

A

Kymera Therapeutics has a consensus price target of $50.63.

Q

What is the current price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $40.9 last updated December 20, 2024 at 7:54 PM EST.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There are no upcoming dividends for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q4 earnings are confirmed for Thursday, February 20, 2025.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch